{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:48:50Z","timestamp":1782409730571,"version":"3.54.5"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Craniopharyngiomas are classified as adamantinomatous or papillary subtypes. Papillary craniopharyngiomas harbor BRAF V600E mutations and demonstrate high response rates to BRAF\/MEK inhibition. Craniopharyngiomas involving the hypothalamus are common and carry high surgical morbidity, including endocrine, metabolic, and neurocognitive complications. Therefore, reliable preoperative identification of papillary hypothalamic tumors could support consideration of biopsy followed by targeted therapy, potentially avoiding high-risk surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>This study is a single-center retrospective study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 61 adult patients with hypothalamic craniopharyngiomas. We defined a novel MRI biomarker, the polystyrene beads sign, as an agglomerate of small, rounded, contrast-enhancing nodules on high-resolution T1-weighted post-contrast MRI. Six independent clinicians, blinded to histopathology, evaluated the presence of the sign. Diagnostic performance (sensitivity, specificity, accuracy) and intra- and interrater reliability were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The polystyrene beads sign identified papillary tumors with 92% sensitivity, 98% specificity, and 96% overall diagnostic accuracy. Intrarater reliability across 2 separate readings was high, and interrater reliability among all 6 clinicians was excellent. After a brief calibration session, the sign was consistently recognizable and distinguishable from enhancement patterns observed in adamantinomatous tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The polystyrene beads sign is a simple and reproducible preoperative MRI marker that may help identify papillary hypothalamic craniopharyngiomas. These findings support further evaluation in multicenter studies before clinical implementation. Its recognition may contribute to imaging-based diagnostic strategies, including selection of patients for confirmatory biopsy, molecular testing, and subsequent targeted therapy in appropriate cases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvag108","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T11:53:31Z","timestamp":1781870011000},"page":"857-865","source":"Crossref","is-referenced-by-count":0,"title":["The polystyrene beads sign: a simple MRI marker for the preoperative diagnosis of papillary hypothalamic craniopharyngiomas"],"prefix":"10.1093","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0735-8278","authenticated-orcid":false,"given":"Bertrand","family":"Baussart","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Assistance Publique-H\u00f4pitaux de Paris, Lariboisi\u00e8re University Hospital , Paris 75010 ,","place":["France"]},{"name":"Universit\u00e9 Paris Cit\u00e9, CNRS, INSERM, Institut Cochin , Paris F-75014 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Fava","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Assistance Publique-H\u00f4pitaux de Paris, Lariboisi\u00e8re University Hospital , Paris 75010 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0360-0875","authenticated-orcid":false,"given":"Maxime","family":"Barat","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, CNRS, INSERM, Institut Cochin , Paris F-75014 ,","place":["France"]},{"name":"Department of Radiology, H\u00f4pital Cochin, AP-HP. Centre Universit\u00e9 Paris Cit\u00e9 , 27 rue du Faubourg Saint-Jacques, Paris 75014 ,","place":["France"]},{"name":"Universit\u00e9 Paris Cit\u00e9 , 85 Boulevard Saint-Germain, UFR Medicine, Paris 75006 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Passeri","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Assistance Publique-H\u00f4pitaux de Paris, Lariboisi\u00e8re University Hospital , Paris 75010 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8732-5603","authenticated-orcid":false,"given":"Anthony","family":"Dohan","sequence":"additional","affiliation":[{"name":"Department of Radiology, H\u00f4pital Cochin, AP-HP. Centre Universit\u00e9 Paris Cit\u00e9 , 27 rue du Faubourg Saint-Jacques, Paris 75014 ,","place":["France"]},{"name":"Universit\u00e9 Paris Cit\u00e9 , 85 Boulevard Saint-Germain, UFR Medicine, Paris 75006 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Ferlendis","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Assistance Publique-H\u00f4pitaux de Paris, Lariboisi\u00e8re University Hospital , Paris 75010 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Jouinot","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, CNRS, INSERM, Institut Cochin , Paris F-75014 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9508-8956","authenticated-orcid":false,"given":"Jennifer","family":"Arrondeau","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris , Paris 75014 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3156-475X","authenticated-orcid":false,"given":"Julian","family":"Jacob","sequence":"additional","affiliation":[{"name":"Sorbonne University, Radiation Oncology Department, Assistance Publique-H\u00f4pitaux de Paris, La Piti\u00e9-Salp\u00eatri\u00e8re University Hospital , Paris 75013 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7156-9750","authenticated-orcid":false,"given":"Valentin","family":"Calugaru","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Proton Therapy Centre, Institut Curie , Orsay, Paris, 75005 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7458-7102","authenticated-orcid":false,"given":"Mirella","family":"Hage","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Ambroise Par\u00e9 , Boulogne Billancourt 92100 ,","place":["France"]},{"name":"Universit\u00e9 de Versailles Saint-Quentin-en-Yvelines UFR des Sciences de la Sant\u00e9 Simone Veil , Montigny-le- Bretonneux 78180 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8462-7753","authenticated-orcid":false,"given":"Philippe","family":"Touraine","sequence":"additional","affiliation":[{"name":"Sorbonne University, Department of Endocrinology and Reproductive Medicine, Centre de R\u00e9f\u00e9rence des Maladies Endocriniennes Rares de la Croissance et du D\u00e9veloppement, CRMERC, Endo-ERN, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, AP-HP , Paris 75013 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8342-1596","authenticated-orcid":false,"given":"Camille","family":"Vatier","sequence":"additional","affiliation":[{"name":"Sorbonne University, Endocrine Unit, Reproductive Medicine, Centre de R\u00e9f\u00e9rence des Maladies Endocriniennes Rares de la Croissance et du D\u00e9veloppement (CRMERC), Endo-ERN (id 739527), Saint-Antoine Hospital, AP-HP , Paris 75012 ,","place":["France"]},{"name":"INSERM UMRS938, Saint-Antoine Research Center, Sorbonne University , Paris 75012 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Laloi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Assistance Publique-H\u00f4pitaux de Paris, Lariboisi\u00e8re University Hospital , Paris 75010 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Courtillot","sequence":"additional","affiliation":[{"name":"Sorbonne University, Department of Endocrinology and Reproductive Medicine, Centre de R\u00e9f\u00e9rence des Maladies Endocriniennes Rares de la Croissance et du D\u00e9veloppement, CRMERC, Endo-ERN, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, AP-HP , Paris 75013 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2551-3008","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Bertherat","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, CNRS, INSERM, Institut Cochin , Paris F-75014 ,","place":["France"]},{"name":"Department of Endocrinology, Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Cochin, Center for Rare Adrenal Diseases , Paris 75014 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6245-4487","authenticated-orcid":false,"given":"Chiara","family":"Villa","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, CNRS, INSERM, Institut Cochin , Paris F-75014 ,","place":["France"]},{"name":"Department of Pathology, Assistance Publique-H\u00f4pitaux de Paris, Lariboisi\u00e8re University Hospital , Paris 75010 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9590-0906","authenticated-orcid":false,"given":"Guillaume","family":"Assi\u00e9","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, CNRS, INSERM, Institut Cochin , Paris F-75014 ,","place":["France"]},{"name":"Department of Endocrinology, Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Cochin, Center for Rare Adrenal Diseases , Paris 75014 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Froelich","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Assistance Publique-H\u00f4pitaux de Paris, Lariboisi\u00e8re University Hospital , Paris 75010 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"issue":"Suppl 5","key":"2026062513264353900_lvag108-B1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","article-title":"CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2012\u20132016","volume":"21","author":"Ostrom","year":"2019","journal-title":"Neuro Oncol."},{"issue":"1","key":"2026062513264353900_lvag108-B2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41572-019-0125-9","article-title":"Craniopharyngioma","volume":"5","author":"M\u00fcller","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"2026062513264353900_lvag108-B3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s10143-018-1010-9","article-title":"Craniopharyngioma adherence: a reappraisal of the evidence","volume":"43","author":"Prieto","year":"2020","journal-title":"Neurosurg Rev"},{"issue":"14","key":"2026062513264353900_lvag108-B4","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.21037\/atm-21-2924","article-title":"Clinical impact of craniopharyngioma classification based on location origin: a multicenter retrospective study","volume":"9","author":"Hu","year":"2021","journal-title":"Ann Transl Med"},{"key":"2026062513264353900_lvag108-B5","doi-asserted-by":"publisher","first-page":"e803","DOI":"10.1016\/j.wneu.2019.06.037","article-title":"Is gross total resection reasonable in adults with craniopharyngiomas with hypothalamic involvement?","volume":"129","author":"Apra","year":"2019","journal-title":"World Neurosurg"},{"key":"2026062513264353900_lvag108-B6","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3171\/2020.7.JNS20257","article-title":"Endoscopic endonasal versus transcranial surgery for primary resection of craniopharyngiomas based on a new QST classification system: a comparative series of 315 patients","volume":"135","author":"Fan","year":"2021","journal-title":"J Neurosurg"},{"issue":"8","key":"2026062513264353900_lvag108-B7","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1210\/clinem\/dgae049","article-title":"Prognostic impact of hypothalamic perforation in adult patients with craniopharyngioma: a cohort study","volume":"109","author":"Gaillard","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026062513264353900_lvag108-B8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3171\/2014.3.JNS131521","article-title":"The endoscopic endonasal approach for the management of craniopharyngiomas: a series of 103 patients","volume":"121","author":"Cavallo","year":"2014","journal-title":"J Neurosurg"},{"key":"2026062513264353900_lvag108-B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bas.2022.100878","article-title":"Surgical management of giant pituitary neuroendocrine tumors: meta-analysis and consensus statement on behalf of the EANS skull base section","volume":"2","author":"Cossu","year":"2022","journal-title":"Brain Spine"},{"issue":"5","key":"2026062513264353900_lvag108-B10","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3171\/2023.3.JNS222302","article-title":"The influence of tumor topography on the surgical outcome of craniopharyngiomas","volume":"139","author":"Sadhasivam","year":"2023","journal-title":"J Neurosurg"},{"issue":"Suppl 6","key":"2026062513264353900_lvag108-B11","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/j.wneu.2014.07.023","article-title":"The role of the endoscopic endonasal route in the management of craniopharyngiomas","volume":"82","author":"Cavallo","year":"2014","journal-title":"World Neurosurg"},{"issue":"8","key":"2026062513264353900_lvag108-B12","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"issue":"1","key":"2026062513264353900_lvag108-B13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12943-021-01468-7","article-title":"Characterization of novel CTNNB1 mutation in craniopharyngioma by whole-genome sequencing","volume":"20","author":"He","year":"2021","journal-title":"Mol Cancer"},{"issue":"2","key":"2026062513264353900_lvag108-B14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10143-009-0186-4","article-title":"The role of fractionated radiotherapy and radiosurgery in the management of patients with craniopharyngioma","volume":"32","author":"Minniti","year":"2009","journal-title":"Neurosurg Rev"},{"key":"2026062513264353900_lvag108-B15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.radonc.2020.11.014","article-title":"ESTRO ACROP guideline for target volume delineation of skull base tumors","volume":"156","author":"Combs","year":"2021","journal-title":"Radiother Oncol"},{"issue":"4","key":"2026062513264353900_lvag108-B16","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/neuonc\/noac210","article-title":"Proton therapy for adult craniopharyngioma: experience of a single institution in 91 consecutive patients","volume":"25","author":"Beddok","year":"2023","journal-title":"Neuro Oncol"},{"issue":"2","key":"2026062513264353900_lvag108-B17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ng.2868","article-title":"Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas","volume":"46","author":"Brastianos","year":"2014","journal-title":"Nat Genet"},{"issue":"12","key":"2026062513264353900_lvag108-B18","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.1210\/jc.2019-01299","article-title":"The medical therapy of craniopharyngiomas: the way ahead","volume":"104","author":"Alexandraki","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2026062513264353900_lvag108-B19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.882381","article-title":"Neoadjuvant B-RAF and MEK inhibitor targeted therapy for adult papillary craniopharyngiomas: a new treatment paradigm","volume":"13","author":"Calvanese","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2026062513264353900_lvag108-B20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1056\/NEJMoa2213329","article-title":"BRAF\u2013MEK inhibition in newly diagnosed papillary craniopharyngiomas","volume":"389","author":"Brastianos","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"2026062513264353900_lvag108-B21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11060-025-05318-0","article-title":"Efficacy and safety of BRAF-MEK dual inhibition in BRAF-V600E mutated papillary craniopharyngioma: a systematic review","volume":"176","author":"G\u00fclsuna","year":"2025","journal-title":"J Neurooncol"},{"issue":"2","key":"2026062513264353900_lvag108-B22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/ejendo\/lvae091","article-title":"BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort study","volume":"191","author":"De Alcubierre","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026062513264353900_lvag108-B23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11060-025-04969-3","article-title":"Papillary craniopharyngioma management in the era of BRAF and MEK inhibition","volume":"173","author":"Damante","year":"2025","journal-title":"J Neurooncol"},{"issue":"3","key":"2026062513264353900_lvag108-B24","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s11060-025-04942-0","article-title":"Targeted treatment for craniopharyngioma","volume":"172","author":"Stec","year":"2025","journal-title":"J Neurooncol"},{"issue":"10","key":"2026062513264353900_lvag108-B25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41571-023-00807-5","article-title":"BRAF plus MEK inhibition effective in papillary craniopharyngioma","volume":"20","author":"Sidaway","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"2026062513264353900_lvag108-B26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/neuros\/nyy569","article-title":"A clinical rule for preoperative prediction of BRAF mutation Status in craniopharyngiomas","volume":"85","author":"Fujio","year":"2019","journal-title":"Neurosurgery"},{"issue":"5","key":"2026062513264353900_lvag108-B27","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1007\/s10143-022-01848-7","article-title":"Duct-like diverticulum at the base of third ventricle tumors: a morphological signature diagnostic of papillary craniopharyngioma","volume":"45","author":"Pascual","year":"2022","journal-title":"Neurosurg Rev"},{"issue":"9","key":"2026062513264353900_lvag108-B28","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3174\/ajnr.A7602","article-title":"Duct-like recess in the infundibular portion of third ventricle craniopharyngiomas: an MRI sign identifying the papillary type","volume":"43","author":"Pascual","year":"2022","journal-title":"AJNR Am J Neuroradiol"},{"issue":"9-10","key":"2026062513264353900_lvag108-B29","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1159\/000506904","article-title":"Biological behaviour of craniopharyngiomas","volume":"110","author":"Martinez-Barbera","year":"2020","journal-title":"Neuroendocrinology"},{"issue":"1","key":"2026062513264353900_lvag108-B30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"issue":"Suppl 1","key":"2026062513264353900_lvag108-B31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3171\/ped.2007.106.1.3","article-title":"Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement","volume":"106","author":"Puget","year":"2007","journal-title":"J Neurosurg"},{"issue":"2","key":"2026062513264353900_lvag108-B32","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/00006123-200002000-00007","article-title":"Long-term outcomes for surgically resected craniopharyngiomas","volume":"46","author":"Duff","year":"2000","journal-title":"Neurosurgery"},{"key":"2026062513264353900_lvag108-B33","doi-asserted-by":"publisher","first-page":"e447","DOI":"10.1016\/j.wneu.2020.08.184","article-title":"Endoscopic endonasal approach for craniopharyngiomas with intraventricular extension: case series, long-term outcomes, and review","volume":"144","author":"Algattas","year":"2020","journal-title":"World Neurosurg"},{"issue":"2","key":"2026062513264353900_lvag108-B34","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv310","article-title":"Dramatic response of BRAF V600E mutant papillary craniopharyngioma to targeted therapy","volume":"108","author":"Brastianos","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2026062513264353900_lvag108-B35","doi-asserted-by":"publisher","DOI":"10.1530\/EO-24-0024","article-title":"Treatment with BRAF\/MEK: inhibitors in mutant BRAF V600E papillary craniopharyngioma","volume":"4","author":"Erfurth","year":"2024","journal-title":"Endocr Oncol"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvag108\/68577455\/lvag108.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/194\/6\/857\/68577455\/lvag108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/194\/6\/857\/68577455\/lvag108.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:26:50Z","timestamp":1782408410000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/194\/6\/857\/8713377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvag108","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,6,1]]}}}